RT Book, Section A1 Murri, PharmD, MBA, Nelda A2 Brunton, Laurence L. A2 Hilal-Dandan, Randa A2 Knollmann, Björn C. SR Print(0) ID 1164576105 T1 Goodman & Gilman Year in Review New and Noteworthy FDA Regulatory Actions T2 Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 13e YR 2017 FD 2017 PB McGraw-Hill Education PP New York, NY SN 9781259584732 LK hemonc.mhmedical.com/content.aspx?aid=1164576105 RD 2024/10/07 AB In 2016 the U.S. Food and Drug Administration (FDA) approved 22 new drugs and granted 32 noteworthy biologics licenses. Among the 22 new drugs are: